Nexeon Medsystems Inc

Equities

NXNN

US65342G2030

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 10:06:42 2023-09-14 am EDT			5-day change	1st Jan Change
0.0001 ^USD	-.--%		-.--%	-.--%

2021	Nexeon Medsystems Inc. Announces Resignation of Miro Zecevic as Member of the Board of Directors	CI
2019	Nexeon Medsystems Inc. Announces the Resignation of Wes Ditmer as A Member of the Board of Directors	CI

Nexeon MedSystems, Inc. acquired a portfolio of neuromodulation patents from NeuroTek Medical Inc.

April 20, 2016

Nexeon MedSystems, Inc. acquired a portfolio of neuromodulation patents from NeuroTek Medical Inc. on April 21, 2016. Alejandro Covalin will join Nexeon as Chief Scientific Officer.

Nexeon MedSystems, Inc. completed the acquisition of a portfolio of neuromodulation patents from NeuroTek Medical Inc. on April 21, 2016.

Latest news about Nexeon Medsystems Inc

Nexeon Medsystems Inc. Announces Resignation of Miro Zecevic as Member of the Board of Directors	21-04-09	CI
Nexeon Medsystems Inc. Announces the Resignation of Wes Ditmer as A Member of the Board of Directors	19-04-01	CI
Nexeon Medsystems Inc. Reports Consolidated Earnings Results for the Third Quarter Ended September 30, 2018	18-11-19	CI
Nexeon MedSystems Receives Grant Matching Funds from the Puerto Rico Science, Technology, and Research Trust	18-11-05	CI
Nexeon MedSystems Inc. Announces Resignation of Brian Blischak as President and Chief Commercial Officer	18-11-01	CI
Nexeon MedSystems Inc. Reports Consolidated Earnings Results for the Second Quarter Ended June 30, 2018	18-08-13	CI
Nexeon MedSystems Inc. will Change its Ticker to NXNN from NXNND	18-07-26	CI
Nexeon MedSystems Inc. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2018	18-05-21	CI
Nexeon Medsystems Inc Announces Board Changes	18-04-24	CI
Nexeon MedSystems Inc. Announces Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2017	18-04-05	CI
Nexeon MedSystems Inc. Auditor Raises 'Going Concern' Doubt	18-04-04	CI
Nexeon MedSystems Inc. Announces Board Changes	17-11-08	CI
Nexeon MedSystems Inc. Begins Clinical Study with Newly Developed Non-Invasive Vagus Nerve Stimulator	17-10-25	CI
Nexeon MedSystems Inc. announced that it expects to receive $1 million in funding from Leonite Capital LLC	17-08-20	CI
Nexeon MedSystems Inc. announced that it has received $1.17 million in funding	17-07-19	CI
Nexeon MedSystems Inc. Appoints Daniel Powell as the Vice President, Sales and Marketing	17-06-28	CI
Nexeon MedSystems Inc. announced a financing transaction	17-04-20	CI
Nexeon MedSystems, Inc. Auditor Raises 'Going Concern' Doubt	17-03-28	CI
Nexeon MedSystems Inc Announces Board Changes	17-02-28	CI
Nexeon MedSystems, Inc. acquired an unknown stake in MicroTransponder, Inc. from Rosellini Scientific, LLC.	17-01-18	CI
Nexeon MedSystems, Inc. announced that it has received $4.3 million in funding	17-01-18	CI
Nexeon MedSystems Inc Announces Executive Appointments	16-12-29	CI
Nexeon MedSystems, Inc. acquired Nexeon MedSystems, Inc..	16-08-15	CI
Nexeon MedSystems, Inc. Auditor Raises 'Going Concern' Doubt	16-07-05	CI
Nexeon MedSystems, Inc. acquired a portfolio of neuromodulation patents from NeuroTek Medical Inc.	16-04-20	CI

Chart Nexeon Medsystems Inc

Duration

Period

More charts

Company Profile

Nexeon MedSystems Inc is a medical device development and manufacturing company. It is focused on providing neurostimulation products designed to improve the quality of life of patients suffering from debilitating neurological diseases. Its primary purposes are to develop and commercialize its neurostimulation technology platform for the treatment of various disorders via electrical stimulation of tissues associated with the nervous system. Its operations include operations of its subsidiaries, which include Nexeon MedSystems Europe, SARL (Nexeon Europe), Nexeon MedSystems Puerto Rico Operating Company Corporation (NXPROC), NMB (which owns and operates Medi-Line), SA, and Pulsus Medical, LLC (Pulsus). Nexeon Europe is the holding company for NXPROC and NMB. NXPROC is focused on advanced computational biology and deep learning utilization associated with the Internet of Medical Things technology. Pulsus conducts research and development related to cardiovascular disease technology.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NEXEON MEDSYSTEMS INC	-.--%	203
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology